Verve Therapeutics Inc.
13F holders, Q2 2025 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Verve Therapeutics Inc. in their 13F filings. The largest holder was Murphy & Mullick Capital Management Corp ($0).
- Company
- Verve Therapeutics Inc.
- CUSIP
- 925CVR011
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Murphy & Mullick Capital Management Corp | 0.00% | New | 43 | $0 |
"% of holder's portfolio" is VERVE THERAPEUTICS INC's weight in each manager's 13F, not the share of Verve Therapeutics Inc. the manager owns.